Evidence-Based Medicine Electronic Decision Support Study (EBMeDS)
|ClinicalTrials.gov Identifier: NCT00915304|
Recruitment Status : Completed
First Posted : June 8, 2009
Last Update Posted : December 18, 2012
The purpose of this study is to analyze the effect of the Evidence-Based Medicine electronic Decision Support (EBMeDS) automatic reminders in primary health care.
Hypothesis (1)is that in the intervention group the total number of EBMeDS reminders will decrease compared to the control group.
Hypothesis (2) is that in the intervention group the quality measures will increase faster compared to the control group at follow-up time.
|Condition or disease||Intervention/treatment||Phase|
|Decision Support Systems, Clinical||Behavioral: The EBMeDS reminders||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12101 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Health Services Research|
|Official Title:||Patient Specific Automatic Reminders in Primary Care - the EBMeDS Randomised Trial|
|Study Start Date :||June 2009|
|Primary Completion Date :||February 2011|
|Study Completion Date :||February 2011|
Behavioral: The EBMeDS reminders
Phase I: EBMeDS reminders specific to the visiting or caring patient and his/her clinical problem are generated when the practitioner uses the electronic patient record. During visits of intervention group patients the EBMeDS reminders will be shown on screen to the practitioner.
Phase II: As phase I and in addition, results of the Virtual Health Check (VHC) of all the intervention group patients will be shown to the practitioners.Phase II will be fulfilled in Autumn 2010 and follow-up time will be about 3 months.
- The number of reminders triggered (in relation to the number of eligible patients, Ri/Ni) during repeated Virtual Health Checks (VHCs) [ Time Frame: Follow-up time max one and half year ]VHC will be performed once a week for the whole study population, beginning at baseline and before randomisation. The main outcome measure is Ri/Ni at follow-up time after commencement of the study where Ri is the total number of reminders triggered by the patient record data in intervention and in control group at the time of analysis, and Ni is the total number of patients.
- Specific clinical measures compared to an intervention and a control groupClinical measures as mean values of laboratory parameters, for example a mean level of HbA1c, a mean level of total cholesterol.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00915304
|University of Tampere; School of Health Sciences|
|Tampere, Finland, 33014|
|Study Director:||Pekka Rissanen, Professor||University of Tampere; School of Health Sciences|
|Principal Investigator:||Tiina Kortteisto, MSc||University of Tampere; School of Health Sciences|